Skip to Content Facebook Feature Image

Experic Announces the Appointment of Jeffrey Shane as Chief Commercial Officer

News

Experic Announces the Appointment of Jeffrey Shane as Chief Commercial Officer
News

News

Experic Announces the Appointment of Jeffrey Shane as Chief Commercial Officer

2025-09-03 20:00 Last Updated At:20:30

CRANBURY, N.J.--(BUSINESS WIRE)--Sep 3, 2025--

Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the appointment of Jeffrey Shane as its Chief Commercial Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903886978/en/

Mr. Shane brings nearly three decades of experience in biopharmaceutical manufacturing, including serving as President of the globally recognized equipment manufacturer, Harro Höfliger, Experic’s long standing strategic equipment partner. He has also been a member of Experic’s Board of Directors since the company’s launch in 2018.

“We are delighted to welcome Jeffrey into this role,” said David Wood, Chairman & CEO of Experic. “His distinguished career at Harro Höfliger, combined with his seven years of board service at Experic, uniquely position him to lead our commercial team and support our growth.”

During his tenure at Harro Höfliger, the company established itself as a premium equipment supplier to the biopharmaceutical industry. Under his leadership, the business expanded beyond equipment to offer services supporting clients from development through commercialization via its Pharma Services Division. Recognizing a gap in their offering for a clinical trial materials solution inspired the creation of Experic, underscoring the deep connection between the two organizations.

"Having served on Experic’s Board of Directors since its inception, I have an in-depth understanding of the company’s unique capabilities and its mission,” said Mr. Shane. “I am honored to step into the role of Chief Commercial Officer and look forward to working closely with the leadership team and our talented commercial group to drive the next phase of Experic’s growth."

Experic’s unique partnership with Harro Höfliger brings industry-leading technology to Experic’s state-of-the-art facility in New Jersey, including some of the most advanced capsule filling and inhalation drug development capabilities in the industry. Innovative machine platforms and packaging systems ensure that Experic’s customers benefit from flexible, scalable solutions tailored to their needs.

About Experic

Experic is a contract development and manufacturing organization (CDMO) and clinical trial supply services company dedicated to revolutionizing pharmaceutical development, manufacturing, and clinical trial supply. Established in 2018, Experic offers a comprehensive suite of services, including process development, analytical and formulation development, clinical and commercial manufacturing, and clinical packaging and logistics. Specializing in challenging powders and inhalation products, our expertise encompasses capsules, and low-dose dry powder inhalation therapies. Operating from our state-of-the-art, Class A cGMP facility in Cranbury, New Jersey, as well as our Clinical Supply Center facility in Kilbeggan, Ireland, we manage the global delivery of high-quality products, even for expedited projects. Our team of industry leaders brings decades of experience in pharmaceutical product development and clinical trial supplies, ensuring strategic vision and execution for every project. For more information, please visit www.expericservices.com.

Jeffrey Shane is chief commercial officer at Experic, providing leadership in commercial activities and business development promoting Experic’s strengths in contract development and manufacturing (CDMO) and clinical trial supply services.

Jeffrey Shane is chief commercial officer at Experic, providing leadership in commercial activities and business development promoting Experic’s strengths in contract development and manufacturing (CDMO) and clinical trial supply services.

LAS VEGAS (AP) — Vegas Golden Knights captain Mark Stone, who has missed the past five games because of a lower-body injury, not only played in Sunday's 5-3 victory over the Colorado Avalanche, his goal sparked the comeback.

Stone scored a power-play goal 19 seconds into the second period to start a rally from a 3-0 deficit and ultimately give the Golden Knights a 3-0 series lead.

“I don’t like watching, ever. I want to play every game," Stone said. "It’s been an unfortunate part of my career, sitting out. This time of year it’s definitely harder. But when the guys are playing the way they’re playing it makes it a little bit easier. Come to the rink with a smile on my face every day. Helps when you’re winning. It’s great to be around the guys and now it’s great to be back on the bench.”

Golden Knights coach John Tortorella announced before the game Stone would be back in the lineup.

”His talent speaks for itself, but his character and leadership, just to have him back in the room, get his voice back, is going to be huge for our team," Golden Knights defenseman Noah Hanifin said. “Any time he comes back, it's like he didn't miss a beat.”

Stone, hurt in Game 3 of the second-round series at Anaheim, showed few if any limitations while taking part in an optional skate Saturday. He also skated when the team was in Denver for the first two games of the series.

His 28 goals and 73 points in the regular season were Stone’s highest in seven years, and he has produced four goals and five assists in 10 playoff games this year.

“No one wants to be out there more than Mark,” Hanifin said. “He's one of the most competitive guys I've played with in my career.”

AP NHL: https://apnews.com/hub/stanley-cup and https://apnews.com/hub/nhl

Vegas Golden Knights center Tomas Hertl, left, celebrates his goal with right wing Mark Stone during the third period in Game 3 of the Western Conference finals NHL hockey Stanley Cup playoff series against the Colorado Avalanche, Sunday, May 24, 2026, in Las Vegas. (AP Photo/Mark J. Terrill)

Vegas Golden Knights center Tomas Hertl, left, celebrates his goal with right wing Mark Stone during the third period in Game 3 of the Western Conference finals NHL hockey Stanley Cup playoff series against the Colorado Avalanche, Sunday, May 24, 2026, in Las Vegas. (AP Photo/Mark J. Terrill)

Colorado Avalanche center Nazem Kadri, second fro, right, trips after scoring on Vegas Golden Knights goaltender Carter Hart, right, as right wing Mark Stone, left, and defenseman Dylan Coghlan watch during the first period in Game 3 of the Western Conference finals NHL hockey Stanley Cup playoff series Sunday, May 24, 2026, in Las Vegas. (AP Photo/Mark J. Terrill)

Colorado Avalanche center Nazem Kadri, second fro, right, trips after scoring on Vegas Golden Knights goaltender Carter Hart, right, as right wing Mark Stone, left, and defenseman Dylan Coghlan watch during the first period in Game 3 of the Western Conference finals NHL hockey Stanley Cup playoff series Sunday, May 24, 2026, in Las Vegas. (AP Photo/Mark J. Terrill)

Recommended Articles